LNTH News and Press, Lantheus Holdings Inc. From 06/18/21

It has been nearly one year since I took a good look at Lantheus Holdings, but PYLARIFY's approval has forced me to reassess the ticker and my investment strategy. PYLARIFY has the potential to be a game-changer in prostate cancer diagnosis and improve patient outcomes. The company ha...

Lantheus Holdings Inc. (NASDAQ:LNTH) traded today at a new 52-week high of $25.01. Approximately 371,000 shares have changed hands today, as compared to an average 30-day volume of 989,000 shares. There is potential upside of 25.1% for shares of Lantheus Holdings Inc. based on a current ...

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and follow serious medical conditions, announ...

Lantheus Holdings Inc. (NASDAQ:LNTH) traded at a new 52-week high today of $25.63. This new high was reached on below average trading volume as 371,000 shares traded hands, while the average 30-day volume is approximately 940,000 shares. Lantheus Holdings Inc caters to the United States ...

Shares of Lantheus Holdings Inc. (NASDAQ:LNTH) traded today at $24.86, eclipsing its 52-week high. This new high was reached on below average trading volume as 371,000 shares traded hands, while the average 30-day volume is approximately 940,000 shares. In the past 52 weeks, shares of La...

Lantheus Holdings Inc. (NASDAQ:LNTH) traded today at a new 52-week high of $24.76. So far today approximately 371,000 shares have been exchanged, as compared to an average 30-day volume of 940,000 shares. Lantheus Holdings Inc caters to the United States healthcare sector with the develo...

Lantheus Holdings Inc. (NASDAQ:LNTH) traded today at a new 52-week high of $24.85. This new high was reached on below average trading volume as 371,000 shares traded hands, while the average 30-day volume is approximately 940,000 shares. In the past 52 weeks, shares of Lantheus Holdings ...

Shares of Lantheus Holdings (NASDAQ: LNTH) were soaring 17.1% as of 11:01 a.m. EDT on Thursday. The big jump came after the company announced that the Food and Drug Administration had approved Pylarify, an imaging agent used to identify prostate cancer. Today's significant gain ...

Vertex Energy (VTNR) +98% on deal for Shell's Mobile refinery.Moxian (MOXC) +37%.1847 Goedeker (GOED) +22%.SOS Limited (SOS) +14%.Bit Digital (BTBT) +13%.Vir Biotechnology (VIR) +9% as GSK/Vir COVID-19 biologic wins FDA Emergency Use Authorization.LAIX (LAIX) +12% on Q1 results...

Lantheus Holdings (LNTH) has climbed ~21.0% in the premarket after announcing the FDA approval for PYLARIFY in the identification of suspected metastasis or recurrence of prostate cancer.PYLARIFY is an F 18-labeled prostate-specific membrane antigen ((PSMA)) targeted posit...